The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Indivior Uk competitive analysis

Loading summary...

Latest patents of Indivior Uk opposed by its competitors

Explore Indivior Uk's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3215223
Jul 1, 2020Buprenorphine Dosing Regimens1
EP2579874
Jan 10, 2018Injectable Flowable Composition Comprising Buprenorphine1

Latest PTAB cases involving Indivior Uk

Discover the latest PTAB cases involving Indivior Uk, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 14, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Indivior Uk

IPR2019-00328Nov 13, 2018DR REDDYS LABORATORIESINDIVIOR UKInstitution Denied
IPR2019-00329Nov 13, 2018DR REDDYS LABORATORIESINDIVIOR UKFinal Written Decision
IPR2016-01113May 31, 2016DR REDDYS LABORATORIESINDIVIOR UKInstitution Denied
IPR2016-00280Dec 3, 2015TEVA PHARMACEUTICALS USAINDIVIOR UKInstitution Denied

Peer Comparison New

IP litigation analysis comparing Indivior Uk with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
INDIVIOR UK - 2 - 4
DR REDDYS LABORATORIES9627 -
ELKINGTON AND FIFE92 - - -
TEVA PHARMACEUTICALS20916 - 12